TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 2.90nMpH: 7.4Assay Description:Compound 2 was examined for its ability to bind human FLAP using a membrane-binding assay. The affinity of Compound 2 for human FLAP was assessed usi...More data for this Ligand-Target Pair